|
Status |
Public on Jun 06, 2016 |
Title |
Transcriptome analysis of patient-derived xenograft models of HER2+ breast cancer brain metastases |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
To gain insights into tumor heterogeneity in anti-cancer drug responses of patient-derived xenograft models of HER2+ breast cancer brain metastases, we performed transcriptome gene expression profiling by Ion AmpliSeqâ„¢ Transcriptome sequencing that targets more than 20,000 human genes. Our data found that all anti-cancer drugs responders have significantly higher expression levels of AKT-mTOR-dependent signature genes as compared to the non-responders, suggesting that most HER2+ breast cancer brain metastases are depend on the AKT-mTOR pathway
|
|
|
Overall design |
Gene expression profiles of five PDX samples were generated by Ion AmpliSeq Transcriptome sequencing, in duplcate, using Ion torrent Proton machine.
|
|
|
Contributor(s) |
Zhao J, Ni J, Xie S |
Citation(s) |
27270588 |
|
Submission date |
Apr 27, 2016 |
Last update date |
May 15, 2019 |
Contact name |
Jean Zhao |
E-mail(s) |
Jean_zhao@dfci.harvard.edu
|
Organization name |
Dana Farber Cancer Institute
|
Department |
Cancer Biology
|
Lab |
Jean Zhao
|
Street address |
450 Brookline Ave, SM936
|
City |
Boston |
State/province |
MA |
ZIP/Postal code |
02215 |
Country |
USA |
|
|
Platforms (1) |
GPL17303 |
Ion Torrent Proton (Homo sapiens) |
|
Samples (10)
|
|
Relations |
BioProject |
PRJNA319811 |
SRA |
SRP074069 |